3 Reasons Cassava Sciences Stock Isn't Worth the Risk

Occam's razor is a philosophical school of thinking that can be simplified as 'the most obvious explanation is most often the truth.' When a stock becomes the battleground of opinion between bulls and bears, the principle can come in handy. After all, the future is unknowable and you need a decision-making framework for when two groups of investors are each convinced something different will happen.

But when the facts themselves are in question, it's often a good idea simply to stay away, at least if you lack deep expertise in the subject matter. That's the case right now with Cassava Sciences (NASDAQ: SAVA). Here are a few reasons I think the obvious thing to do is avoid this controversial biotech.

Image source: Getty Images.

Source Fool.com